(Q37785236)

23 August 2017

title

Clinical genetics of hereditary colorectal cancer (English)

1 reference

23 August 2017

Clinical Genetics of Hereditary Colorectal Cancer (English)

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

6 July 2024

1 reference

genetic predisposition to disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20816577

6 July 2024

author name string

Emily Gloglowski

2

1 reference

23 August 2017

Derek G. Power

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20816577

6 July 2024

Steven M. Lipkin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20816577

6 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20816577

6 July 2024

publication date

1 October 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S088985881000095X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

https://api.elsevier.com/content/article/PII:S088985881000095X?httpAccept=text/plain

6 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Hematology / Oncology Clinics of North America

6 July 2024

published in

1 reference

23 August 2017

volume

24

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

837-859

1 reference

https://opencitations.net/index/coci/api/v1/citations/10.3322/CAAC.20006

23 August 2017

cites work

Cancer statistics, 2009

1 reference

28 May 2022

Global cancer statistics, 2002

1

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Recently identified colon cancer predispositions: MYH and MSH6 mutations

6 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Hereditary colorectal cancer

6 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

A Prospective Study of Family History and the Risk of Colorectal Cancer

6 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Molecular origins of cancer: Molecular basis of colorectal cancer

6 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

MSH6 mutations in hereditary nonpolyposis colon cancer: another slice of the pie

6 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium

6 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations

6 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

The role of hMLH3 in familial colorectal cancer

6 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Mutations of two PMS homologues in hereditary nonpolyposis colon cancer

6 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)

6 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

6 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

6 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Prediction of Lynch syndrome in consecutive patients with colorectal cancer

6 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Rhabdomyosarcoma in patients with constitutional mismatch-repair-deficiency syndrome

6 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Familial colorectal cancer: pathology and molecular characteristics

6 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

6 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Epimutations and cancer predisposition: importance and mechanisms

6 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability

6 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Microsatellite instability in colorectal cancer-the stable evidence

6 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Genetics: Predictive value of KRAS mutations in chemoresistant CRC.

6 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

RAF/RAS oncogenes and mismatch-repair status

6 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.

6 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer

6 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

6 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

6 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.

6 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome

6 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers

6 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Mutations associated with HNPCC predisposition -- Update of ICG-HNPCC/INSiGHT mutation database

6 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families

6 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR).

6 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Feasibility of screening for Lynch syndrome among patients with colorectal cancer

6 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer

6 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum

6 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency

6 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Clinical Findings with Implications for Genetic Testing in Families with Clustering of Colorectal Cancer

6 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer

6 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Prediction of MLH1 and MSH2 Mutations in Lynch Syndrome

6 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Prediction of germline mutations and cancer risk in the Lynch syndrome

6 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability

6 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance

6 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree

6 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history

6 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).

6 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review

6 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

6 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Decrease in mortality in Lynch syndrome families because of surveillance.

6 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

6 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.

6 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Surveillance for Hereditary Nonpolyposis Colorectal Cancer

6 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Segmental vs. extended colectomy: measurable differences in morbidity, function, and quality of life

6 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Decision model of segmental compared with total abdominal colectomy for colon cancer in hereditary nonpolyposis colorectal cancer

6 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect

6 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

6 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

6 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer

6 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Systematic review of microsatellite instability and colorectal cancer prognosis

6 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

6 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

6 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection

6 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

6 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy

6 July 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome

6 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

6 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Papillary thyroid carcinoma associated with familial adenomatous polyposis: molecular analysis of pathogenesis in a family and review of the literature

6 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Risk of hepatoblastoma in familial adenomatous polyposis

6 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Familial adenomatous polyposis (FAP): genotype correlation to FAP phenotype with osteomas and sebaceous cysts

6 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

6 July 2024

The ABC of APC

74

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Biology of the adenomatous polyposis coli tumor suppressor

6 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

The links between axin and carcinogenesis

6 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

APC gene: database of germline and somatic mutations in human tumors and cell lines

6 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome

6 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer.

6 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes

6 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes

6 July 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Genetic predisposition to colorectal cancer

6 July 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Hereditary colorectal cancer-part II.

6 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Guidelines for the clinical management of familial adenomatous polyposis (FAP).

6 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis

6 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Serrated adenomas in FAP. Familial adenomatous polyposis

6 July 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Rectal carcinoma in a patient with familial adenomatous polyposis coli after colectomy with ileorectal anastomosis and consecutive chemoprevention with sulindac suppositories

6 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis

6 July 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Oral contraceptives and polyp regression in familial adenomatous polyposis.

6 July 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Regression of colorectal adenomas with intravenous cytotoxic chemotherapy in a patient with familial adenomatous polyposis

6 July 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Attenuated familial adenomatous polyposis (AFAP). A review of the literature

6 July 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Attenuated familial adenomatous polyposis: an evolving and poorly understood entity

6 July 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Genotype-phenotype correlations in attenuated adenomatous polyposis coli

6 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9.

6 July 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP.

6 July 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.

6 July 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism

6 July 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Correlation of polyp number and family history of colon cancer with germline MYH mutations

6 July 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH

6 July 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations

6 July 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk

6 July 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study

6 July 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

The potential for increased clinical sensitivity in genetic testing for polyposis colorectal cancer through the analysis of MYH mutations in North American patients

6 July 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps

6 July 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Multiple colorectal adenomas--is their number up?

6 July 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Germline susceptibility to colorectal cancer due to base-excision repair gene defects

6 July 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Is prophylactic colectomy indicated in patients with MYH-associated polyposis?

6 July 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Heritable colorectal cancer syndromes: recognition and preventive management

6 July 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Peutz-Jeghers syndrome and management recommendations

6 July 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Very high risk of cancer in familial Peutz-Jeghers syndrome

6 July 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Frequency and spectrum of cancers in the Peutz-Jeghers syndrome

6 July 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

The molecular basis and clinical aspects of Peutz-Jeghers syndrome

6 July 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Molecular basis and diagnostics of hereditary colorectal cancers

6 July 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Peutz-Jeghers syndrome: confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4.

6 July 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Molecular Classification of Patients With Unexplained Hamartomatous and Hyperplastic Polyposis

6 July 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Preventive measures in Peutz-Jeghers syndrome

6 July 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Diagnostic value of endoscopic capsule in patients with obscure digestive bleeding: blinded comparison with video push-enteroscopy

6 July 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

The genetics of hereditary colon cancer

6 July 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

PTEN hamartoma tumor syndrome: an overview

6 July 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Colorectal cancer: mutations in a signalling pathway

6 July 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics

6 July 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Familial colorectal cancer syndrome X.

6 July 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Altered Expression of MLH1, MSH2, and MSH6 in Predisposition to Hereditary Nonpolyposis Colorectal Cancer

6 July 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations.

6 July 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer

6 July 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X

6 July 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway

6 July 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Rare variant hypothesis for multifactorial inheritance: susceptibility to colorectal adenomas as a model

6 July 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

Colorectal polyps in carriers of the APC I1307K polymorphism

6 July 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

New insights into the aetiology of colorectal cancer from genome-wide association studies

6 July 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.HOC.2010.06.006

6 July 2024

Identifiers

1 reference

23 August 2017

1 reference